Search
for
Sort by
Research 151–180 of 1000+
- PATHOGENETIC FEATURES OF THE INFLUENCE OF A PAST CORONAVIRUS INFECTION IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
- Efficacy of autologous stromal vascular fraction injection in the treatment of androgenic alopecia
- Reversible Vision Loss With Pituitary Microadenoma Following PRP Injection for Hair Growth: A Rare Case Report and a Mini‐Review of the Literature
- Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- DISORDERS OF THE NAILS AND HAIR ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Factors Associated with Acute Telogen Effluvium and COVID-19 Infection
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Analyzing the innate immunity of NIH hairless mice and the impact of gut microbial polymorphisms on<i>Listeria monocytogenes</i>infection
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection
- 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS
- Supplemental Material: Tolerability and Efficacy of Unorthodox Dosing Regimens of Tofacitinib and Baricitinib in Pediatric Patients with Moderate to Severe Alopecia Areata
- The Paediatric skin at risk: Challenges in burns, surgery and specific infections
- Clinical Characteristics, Quality of Life, and Risk Factors of Amputation Stump Skin Disease and Stump Fungal Infection in Adult Amputees in Shanghai, China
- A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Alopecia areata universalis showing excellent response to combination treatment modalities
- Generalized Demodicosis and Malasseziosis in a Pug Mix Dog
- A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
- Kerion – rare, but important form of tinea capitis – a case report
- Expanding the Nude SCID/CID Phenotype Associated with FOXN1 Homozygous, Compound Heterozygous, or Heterozygous Mutations
- Homozygous ALOXE3 Nonsense Variant Identified in a Patient with Non-Bullous Congenital Ichthyosiform Erythroderma Complicated by Superimposed Bullous Majocchi’s Granuloma: The Consequences of Skin Barrier Dysfunction